Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Standard Lithium Closes Financing; Works Toward Completion of PFS

In this interview, the Critical Investor and the company CEO delve into the "impressive" capital raise and what it means for the junior's future. Building demonstration plant at Lanxess Project site After Standard Lithium Ltd. (SLL:TSX.V; STLHF:OTCQX)...

Standard Lithium in Final Stages of De-risking New Recovery Method; ...

Standard Lithium in Final Stages of De-risking New Recovery Method; Giant JV Partner Lanxess Will Fully Fund Capex When Successful The Critical Investor delves into this lithium firm's recovery method for its Arkansas project and why it may succeed when other companie...

Standard Lithium Successfully Commissioned Demonstration Plant Despite COVID-19

The Critical Investor takes a look at the current dynamics of the lithium market, and speaks with the Standard Lithium's CEO about the firm's latest news. LiSTR demonstration plant at Lanxess project site After Standard Lithium Ltd. (SLL:TSX.V; ST...

Phase 2 Data from Potential Multibagger Biopharma 'Checks All the Boxes'

The latest clinical trial results are dissected in a ROTH Capital Partners report. In a Sept. 26 research note, ROTH Capital Partners analyst Jerry Isaacson reported that AzurRx BioPharma Inc.'s (AZRX:NASDAQ) Phase 2 OPTION trial for lead candidate MS1819 in cystic ...

Introducing: The Device to Replace Antiquated Paper-Based Systems

(Image via Visionstate Corp. Click to enlarge.) The Internet of Things (IoT) describes the network of physical objects “things” that are embedded with sensors, software, and other technologies for the purpose of connecting and exchanging data ...

Zero-Commission Trading: Risks and Opportunities, Part 1

Part 1: What It All Means for Investors: Online brokers as investments. There's a financial war going on, and the fallout is causing tremors well beyond Wall Street. Investors armed with the right information can make the new zero-commissions standard work to their ad...

Flying Under the Radar with a Possible COVID-19 Treatment

Investors would think a pharmaceutical company heading into Phase 2b/3 human trials for treating the third most malignant disease after lung cancer and pancreatic cancer would draw eyes from major players. If that same company announced it was embarking on Phase2b/3 human tri...

Buzz on the Bullboards: I went to market

From inflation to interest rates, navigating the waters of a sea of global economic uncertainty and confusion, last week was full of tough questions for investors on the Bullboards.We saw some of...

Standard Lithium Arranges C$5 Million Convertible Loan Financing

The Critical Investor delves into a lithium company's financing and its implications. It seems more and more likely that Standard Lithium Ltd. (SLL:TSX.V; STLHF:OTCQX; FRA: S5L) is displaying a serious commitment of giant JV partner Lanxess these days, with constr...

The Russell and Transportation Tell A Completely Different Story

We've been writing about the broader US stock market for many months – highlighting the Pennant/Flag formations that have continued to set up since early 2018. Sometimes, the keys to really understanding what is transpiring behind the scenes in the US markets is to pay attenti...
1 2 3 4 5 6 7 8 9 10 ...